Feb 2023 – Canadian Lung Cancer Conference
📍 Vancouver, Canada
Talk: The Role of Durvalumab / Atezolizumab in Extensive Stage Small Cell Carcinoma of the Lung.
🔗 CLCCO Main Website

May 2023 – Endpoints ASCO Series Webinar
📍 Virtual
Talk: How to Accelerate Development in Novel & Advanced Oncology Therapies – From the Starting Line.
🔗 Webinar – Novotech CRO

Nov 2023 – 7th Annual Patient-Centered Clinical Trial Conference
📍 Montreal, Canada (Colorectal Foundation Canada)
Talk: Real-World Data as a Force for Change.
🔗 Event Details

Dec 2023 – Lung Cancer Voices Podcast (Best of ESMO 2023)
📍 Podcast episode (38 minutes)
Summary: Key highlights from ESMO 2023 in oncology research.
🔗 Podcast Episode

World Conference on Lung Cancer (WCLC 2024)
📍 Singapore
Contribution: Oral presentations (confirmed via UCalgary profile).
🔗 WCLC Website

Other Local/Institutional Events (Grand Rounds, PROPEL updates, seminars)
📍 Calgary, AB and virtual forums

Jan 2025 – Canadian Lung Cancer Conference
📍 Vancouver, Canada
Talk: Navigating HER-2 Altered NSCLC – Antibody Drug Conjugates and Tyrosine Kinase Inhibitors.
🔗 Conference Info

May 2025 – Investures Conference
📍 Calgary, Canada
Talk: Building a Life Science Industry in Alberta.
🔗 Program Agenda – Investures

Sep 26, 2025 – Lung Cancer Summit Series
📍 Philip & Harriet Libin Knowledge Exchange Centre, Calgary, Alberta
In-person and virtual event focused on education, lived experience, and advocacy for lung cancer patients and caregivers.
🔗 Event Details

Oct 2025 – ESMO / Citeline + Novotech Roundtable
📍 Berlin, Germany
Session: Breaking Through The Checkpoint Blockade in Immuno-Oncology.
🔗 ESMO Website

Nov 2025 – Oncology Education “Best of Lung Cancer 2025”
📍 Virtual (Chairing)
🔗 Event Details

Nov 19, 2025 – Real-World Evidence in Oncology Outcomes (RWE O₂) Day
📍 Calgary, Canada (POET Congress partnership)
Focus: RWE in oncology outcomes and policy.
🔗 LinkedIn Event Post

2025 – POET Molecular Rounds (Monthly Virtual Series)
📍 Virtual
Role: Principal POET Ambassador
Focus: Precision oncology, biomarker-driven diagnostics, molecular profiling.
🔗 POET Oncology

2025 – PROPEL Study (Glans-Look Lung Cancer Research Institute)
📍 Calgary, AB
Role: Lead Investigator
Focus: Real-world evidence, patient-reported outcomes, research leadership.
🔗 PROPEL Study – Glans-Look LCRI

Jan 23, 2026 – Best of Oncology West 2026
📍 Virtual
Talk: Speaker in Lung Cancer session reviewing oncology developments.
🔗 Agenda PDF